EGFR and head and neck squamous cell carcinoma: IKKa and IKKb can cooperatively activate NF‐κB and EGFR/AP1 networks of signaling pathways and contribute to the malignant phenotype and the intrinsic or acquired therapeutic resistance of HNSCC 45.